Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation vs General Anesthesia for ERCP
NCT02046590Terminated
- Sponsor
- Erasmus Hospital
- Start
- Feb 2014
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of propofol, sponsored by Erasmus Hospital. Primary endpoint: ERCP success rate at 24 hours. Started Feb 2014; status: terminated.
02
Drugs
propofol
Beyond the preview
Go deeper on NCT02046590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046590.